GSK PLC enters SPERO THERAPEUTICS, INC. with 9.19M shares across direct and indirect positions
This filing by GSK PLC establishes the baseline for all future Form 4 insider transaction reports at SPERO THERAPEUTICS, INC..
Indirect
Filed: 11/14/2022ACC: 0001387131-22-011408
9.19M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
9.19M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned9.19M
Total
9.19M indirect9.19M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 9.19M | Indirect |
| Total | 9.19M | 9.19M indirect |
Derivative Holdings0
No derivative holdings reported